Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancer.
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023
Project: DECIDER
Updated at: 31-12-2023